Evolution of the blood–brain barrier in newly forming multiple sclerosis lesions
Open accessAbstract
Objective: Multiple sclerosis (MS) lesions develop around small, inflamed veins. New lesions enhance with gadolinium on magnetic resonance imaging (MRI), reflecting disruption of the blood–brain barrier (BBB). Single time point results from pathology and standard MRI cannot capture the spatiotemporal expansion of lesions. We investigated the development and expansion of new MS lesions, focusing on the dynamics of BBB permeability. Methods: We performed dynamic contrast‐enhanced (DCE) MRI in relapsing–remitting MS. We obtained data over 65 minutes, during and after gadolinium injection. We labeled spatiotemporal enhancement dynamics as centrifugal when initially central enhancement expanded outward and centripetal when initially peripheral enhancement gradually filled the center. Results: We detected 34 enhancing lesions in 200 DCE‐MRI scans. In 65%, enhancement first appeared as a closed ring; in 18%, as a nodule; and in 18%, as an open ring. Lesions with initially nodular enhancement were smaller than those initially enhancing as rings ( p < 0.0001). All initially nodular lesions enhanced centrifugally, whereas initially ringlike lesions enhanced centripetally, becoming nodular if small (82%) or nearly nodular if larger (18%). Open‐ring lesions were periventricular or juxtacortical and enhanced centripetally. Centrifugally enhancing lesions evolved into centripetally enhancing lesions over several days. Interpretation: The rapid change of enhancement dynamics from centrifugal to centripetal reflects the outward growth of MS lesions around their central vein and suggests that factors mediating lesion growth and tissue repair derive from different locations at different times. We propose a model of new lesion growth that unites our imaging observations with existing pathology data. ANN NEUROL 2011;
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased blood-brain barrier leakage is prominent around new developing multiple sclerosis lesions centralized around small, inflamed veins.
“Interestingly, increased BBB leakage is prominent around new developing MS lesions centralized around small, inflamed veins (190).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 39 · Cited by 174
Research works printed but not linked: 36
- [2]Tan IL van Schijndel RA Pouwels PJ MR venography of multiple sclerosis AJNR Am J Neuroradiol Jun-Jul 2000 21 6 1039 42 10871010 PMC7973892
- [3]Adams CW The onset and progression of the lesion in multiple sclerosis J Neurol Sci Jun 1975 25 2 165 82 1151432
- [4]Barnett MH Prineas JW Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion Ann Neurol Apr 2004 55 4 458 68 15048884
- [5]Henderson AP Barnett MH Parratt JD Prineas JW Multiple sclerosis: distribution of inflammatory cells in newly forming lesions Ann Neurol Dec 2009 66 6 739 53 20035511
- [6]Bruck W Bitsch A Kolenda H Bruck Y Stiefel M Lassmann H Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology Ann Neurol Nov 1997 42 5 783 93 9392578
- [7]Grossman RI Braffman BH Brorson JR Goldberg HI Silberberg DH Gonzalez-Scarano F Multiple sclerosis: serial study of gadolinium-enhanced MR imaging Radiology Oct 1988 169 1 117 22 3420246
- [8]Lassmann H The pathologic substrate of magnetic resonance alterations in multiple sclerosis Neuroimaging Clin N Am Nov 2008 18 4 563 76 ix 19068402
- [9]Katz D Taubenberger J Raine C Mcfarlin D Mcfarland H Gadolinium-Enhancing Lesions on Magnetic-Resonance-Imaging - Neuropathological Findings Annals of Neurology Aug 1990 28 2 243
- [10]Alvarez JI Cayrol R Prat A Disruption of central nervous system barriers in multiple sclerosis Biochim Biophys Acta 7 Jul 2010 20619340
- [11]Mahad DJ Lawry J Howell SJL Woodroofe MN Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse Multiple Sclerosis Mar 2003 9 2 189 98 12708814
- [12]Holman DW Klein RS Ransohoff RM The blood-brain barrier, chemokines and multiple sclerosis Biochim Biophys Acta Feb 2011 1812 2 220 30 20692338 PMC3005102
- [13]Stolp HB Dziegielewska KM Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases Neuropathol Appl Neurobiol Apr 2009 35 2 132 46 19077110
- [14]Capra R Marciano N Vignolo LA Chiesa A Gasparotti R Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis Arch Neurol Jul 1992 49 7 687 9 1497493
- [15]Morgen K Jeffries NO Stone R Ring-enchancement in multiple sclerosis: marker of disease severity Mult Scler Jun 2001 7 3 167 71 11475440
- [16]Davis M Auh S Riva M Ring and nodular multiple sclerosis lesions: a retrospective natural history study Neurology 9 Mar 2010 74 10 851 6 20211910 PMC2839196
- [17]He J Grossman RI Ge Y Mannon LJ Enhancing patterns in multiple sclerosis: evolution and persistence AJNR Am J Neuroradiol Apr 2001 22 4 664 9 11290475 PMC7976005
- [18]Masdeu JC Quinto C Olivera C Tenner M Leslie D Visintainer P Open-ring imaging sign: highly specific for atypical brain demyelination Neurology 11 Apr 2000 54 7 1427 33 10751251
- [19]Bagheri MH Meshksar A Nabavizadeh SA Borhani-Haghighi A Ashjazadeh N Nikseresht AR Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis Acad Radiol Jan 2008 15 1 15 23 18078903
- [20]Lovblad KO Anzalone N Dorfler A MR imaging in multiple sclerosis: review and recommendations for current practice AJNR Am J Neuroradiol Jun 2010 31 6 983 9 20019103 PMC7963928
- [21]Filippi M Enhanced magnetic resonance imaging in multiple sclerosis Mult Scler Oct 2000 6 5 320 6 11064441
- [22]Nessler S Boretius S Stadelmann C Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage Brain Aug 2007 130 2186 98 17617655
- [23]Tofts PS Kermode AG Measurement of the Blood-Brain-Barrier Permeability and Leakage Space Using Dynamic Mr Imaging.1. Fundamental-Concepts Magnetic Resonance in Medicine Feb 1991 17 2 357 67 2062210
- [24]Larsson HBW Stubgaard M Frederiksen JL Jensen M Henriksen O Paulson OB Quantitation of Blood-Brain-Barrier Defect by Magnetic-Resonance-Imaging and Gadolinium-Dtpa in Patients with Multiple-Sclerosis and Brain-Tumors Magnetic Resonance in Medicine Oct 1990 16 1 117 31 2255233
- [25]Kermode AG Tofts PS Thompson AJ Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement Neurology Feb 1990 40 2 229 35 2300240
- [26]Kurtzke JF A new scale for evaluating disability in multiple sclerosis Neurology Aug 1955 5 8 580 3 13244774
- [27]Hawkins CP Landon DN Mackenzie F Mcdonald WI Munro PMG Studies on the Mechanism of Blood-Brain-Barrier Breakdown in Chronic Relapsing Experimental Allergic Encephalomyelitis in the Guinea-Pig Journal of Physiology-London Jul 1990 426 P116 P
- [28]McDonald WI Miller DH Barnes D The pathological evolution of multiple sclerosis Neuropathol Appl Neurobiol Aug 1992 18 4 319 34 1528388
- [29]Fazekas F Soelberg-Sorensen P Comi G Filippi M MRI to monitor treatment efficacy in multiple sclerosis J Neuroimaging Apr 2007 17 Suppl 1 50S 5S 17425736
- [30]Daumer M Neuhaus A Morrissey S Hintzen R Ebers GC MRI as an outcome in multiple sclerosis clinical trials Neurology 24 Feb 2009 72 8 705 11 19073945
- [31]Hochmeister S Grundtner R Bauer J Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis J Neuropathol Exp Neurol Sep 2006 65 9 855 65 16957579
- [32]Wuerfel J Bellmann-Strobl J Brunecker P Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study Brain Jan 2004 127 Pt 1 111 9 14570816
- [33]Napoli I Neumann H Protective effects of microglia in multiple sclerosis Exp Neurol Sep 2010 225 1 24 8 19409897
- [34]Barilaro A Zellini F Caleri F Kinetic of brain MRI gadolinium enhancing lesions in multiple sclerosis European Journal of Neurology Sep 2004 11 20
- [37]Werring DJ Brassat D Droogan AG The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study Brain Aug 2000 123 Pt 8 1667 76 10908196
- [39]Ludemann L Warmuth C Plotkin M Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography Eur J Radiol Jun 2009 70 3 465 74 18359598
- [40]Lacerda S Law M Magnetic resonance perfusion and permeability imaging in brain tumors Neuroimaging Clin N Am Nov 2009 19 4 527 57 19959004
- Authors
- Gaitán, M. I., Shea, C. D., Evangelou, I. E., Stone, R. D., Fenton, K. M., Bielekova, B., Massacesi, L., & Reich, D. S.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Reich, Daniel S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2011-06-27
- Volume
- 70
- Issue
- 1
- Pages
- 22-29
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC3143223
- OpenAlex
- W2156635509
- Cited by
- 174
- References
- 39
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 13 · 2023: 9 · 2022: 13 · 2021: 7 · 2020: 12 · 2019: 10 · 2018: 15 · 2017: 7 · 2016: 19 · 2015: 16 · 2014: 12 · 2013: 10 · 2012: 9
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 NS999999)
- National Institute of Neurological Disorders and Stroke (ZIANS003055, ZIANS003119)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- multiple sclerosis, blood-brain barrier permeability, dynamic contrast-enhanced MRI, lesion growth, gadolinium enhancement, relapsing-remitting multiple sclerosis, perivascular inflammation
- MeSH terms
- Adult, Blood-Brain Barrier, Capillary Permeability, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Relapsing-Remitting, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review